Ascepion Pharmaceuticals, Inc. is a global-leading, innovation-driven biopharmaceutical company founded by oversea returnees in Feb., 2007. Our R&D service has been focused on the development and production of high-quality Active Pharmaceutical Ingredients (APIs), biologically active reference compounds and pharmaceutical intermediates.

Ascepion currently owns a 1400 m2 integrated R&D platform, including departments of Biology, Medicinal Chemistry, Process Chemistry and Quality Control. A well established Quality Assurance (QA) system makes sure that all the products comply with the standards in CHP, USP and/or EP. In last year, up to 50% of our products are supported by Ascepion's intellectual property rights and over 70% APIs are exported to Europe.

Ascepion recognizes that our business relies on a research strategy equally rooted in technology development and customer insights. We, therefore, would like to bring you our best products together with the best services.